After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Alx Oncology Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Alx Oncology Holdings Inc is $608.82M. A total of 0.89 million shares were traded on the day, compared to an average of 381.53K shares.
In the most recent transaction, Pons Jaume sold 20,000 shares of ALXO for 11.15 per share on Apr 04 ’24. After the transaction, the PRESIDENT & CSO now owns 628,359 company shares. In a previous transaction on Mar 14 ’24, Lettmann Jason bought 4,400 shares at 11.31 per share. ALXO shares that CHIEF EXECUTIVE OFFICER owns now total 171,620.
Among the insiders who sold shares, Pinto Shelly disposed of 2,717 shares on Jan 04 ’24 at a per-share price of $13.60. This resulted in the SVP, Finance and CAO holding 78,591 shares of ALXO after the transaction. In another insider transaction, Pons Jaume sold 7,179 shares at $15.04 per share on Dec 29 ’23. Company shares held by the President & CSO now total 618,359.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALXO has a high of $17.42 and a low of $3.94.
As of this writing, ALXO has an earnings estimate of -$0.84 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.64 per share and a lower estimate of -$0.99. The company reported an EPS of -$1.24 in the last quarter, which was -42.50% lower than expectations of -$0.87.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALXO’s latest balance sheet shows that the firm has $363.67M in Cash & Short Term Investments as of fiscal 2021. There were $742.00k in debt and $15.29M in liabilities at the time. Its Book Value Per Share was $3.80, while its Total Shareholder’s Equity was $363.05M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALXO is Buy with a score of 4.71.
